...
首页> 外文期刊>Canadian Journal of Infectious Diseases and Medical Microbiology: Journal Canadien des Maladies Infectieuses >Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010
【24h】

Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010

机译:1995年至2010年加拿大的门诊β-LaccAM抗菌用途纵向监测

获取原文

摘要

INTRODUCTION: β-lactam antimicrobials are the most commonly prescribed group of antimicrobials in Canada, and are categorized by the WHO as critically and highly important antimicrobials for human medicine. Because antimicrobial use is commonly associated with the development of antimicrobial resistance, monitoring the volume and patterns of use of these agents is highly important.OBJECTIVE: To assess the use of penicillin and cephalosporin antimicrobials within Canadian provinces over the 1995 to 2010 time frame according to two metrics: prescriptions per 1000 inhabitant-days and the average defined daily doses dispensed per prescription.METHODS: Antimicrobial prescribing data were acquired from the Canadian Integrated Program for Antimicrobial Resistance Surveillance and the Canadian Committee for Antimicrobial Resistance, and population data were obtained from Statistics Canada. The two measures developed were used to produce linear mixed models to assess differences among provinces and over time for the broad-spectrum penicillin and cephalosporin groups, while accounting for repeated measurements at the provincial level.RESULTS: Significant differences among provinces were found, as well as significant changes in use over time. A 28% reduction in broad-spectrum penicillin prescribing occurred in each province from 1995 to 2010, and a 18% reduction in cephalosporin prescribing occurred in all provinces from 1995 to 2010, with the exception of Manitoba, where cephalosporin prescribing increased by 18%.DISCUSSION: Significant reductions in the use of these important drugs were observed across Canada from 1995 to 2010. Newfoundland and Labrador and Quebec emerged as divergent from the remaining provinces, with high and low use, respectively.
机译:介绍:β-内酰胺抗菌剂是加拿大最常见规定的抗菌药物,并被人类为人类医学的重症和非常重要的抗微生物类别分类。由于抗菌剂使用通常与抗微生物抗性的发展有关,因此监测这些药剂的使用的体积和使用模式非常重要。目的:根据1995年到2010年到2010年时间框架中的加拿大省份的青霉素和头孢菌素抗菌剂的使用两项度量:每1000个居民的处方和每处方分配的平均定义的每日剂量。方法:从加拿大综合抗药性监测和加拿大抗微生物抵抗委员会获得抗微生物的规定数据,从统计数据获得了人口数据加拿大。制定的两种措施用于生产线性混合模型,以评估省份的差异,随着时间的推移,广谱青霉素和头孢菌素组,同时占省级重复的测量。结果:发现各省之间的显着差异随着时间的推移使用的重大变化。从1995年到2010年的每个省发生广谱青霉素规定的28%,脑孢菌素规定的每省发生了18%,从1995年到2010年发生,除了曼尼托巴巴,头孢菌素规定增加18件从1995年到2010年,加拿大观察到使用这些重要药物的使用的重大减少。纽芬兰和拉布拉多和魁北克出现为剩余的省份,分别具有高低利用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号